🇺🇸 FDA
Patent

US 10874649

2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors

granted A61KA61K31/407A61K31/438

Quick answer

US patent 10874649 (2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors) held by Valo Early Discovery, Inc. expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Valo Early Discovery, Inc.
Grant date
Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/407, A61K31/438, A61P, A61P25/00